Form 4: Quest Diagnostics SVP, Clinical Solutions, Karthik Kuppusamy, Reports Stock Disposals to Cover Tax Obligations
SEC Form 4 Filing
Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, reported disposing of common stock to cover tax obligations arising from vesting restricted share units.
Summary
- On February 28, 2024, Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, disposed of 205 shares of common stock at a price of $126.36 to cover tax obligations.
- An additional 68 shares were disposed of at the same price for the same reason.
- Following these transactions, Kuppusamy directly owns 15,124 shares of common stock.
- Kuppusamy also indirectly owns 358 shares through a trust and 1,513 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document reports routine stock transactions for tax purposes.
Industry Context
This is a routine filing related to stock transactions by a company insider. It is common for executives to sell shares to cover tax obligations arising from vesting equity grants.
Stakeholder Impact
- The stock disposal is unlikely to have a significant impact on shareholders as it is a routine transaction.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of stock disposal to satisfy tax obligations. |
| 03/01/2024 | Date of signature by Sean D. Mersten, Attorney in Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.